COURTNEY SANDRIDGE: Open Payments
NPI 1235695768 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 40 payments from 15 companies in 2025. Trend: 2023 $387 · 2024 $168 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $132 |
| Lilly USA, LLC | 8 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| Novo Nordisk Inc | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| ABBVIE INC. | 3 | $50 |
| Dexcom, Inc. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Boston Scientific Corporation | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $32 |
Products named: FREESTYLE LIBRE 3, Kerendia, MOUNJARO, Ozempic, JARDIANCE, Dexcom G6 Transmitter, LINZESS, NEXLETOL.
Industry payments across MS — which companies pay providers there.
